Global Syringes Market to Reach US$24.2 Billion by 2030

The global market for Syringes estimated at US$15.2 Billion in the year 2023, is expected to reach US$24.2 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Prefilled Syringes, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$10.6 Billion by the end of the analysis period. Growth in the Disposable Safety Syringes segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.1 Billion While China is Forecast to Grow at 11.4% CAGR

The Syringes market in the U.S. is estimated at US$4.1 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.7 Billion by the year 2030 trailing a CAGR of 11.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Syringes Market - Key Trends and Drivers Summarized

The global syringes market is witnessing significant growth, driven by the increasing prevalence of chronic diseases and the rising need for medical and diagnostic procedures. As conditions such as diabetes, cancer, and autoimmune diseases become more common, the demand for syringes is on rise due to the frequent need for insulin administration, chemotherapy, and other injectable treatments. The healthcare industry`s response to infectious diseases such as COVID-19 has also accelerated demand, with mass vaccination campaigns necessitating millions of syringes globally. This uptick in chronic and infectious diseases is a primary factor fueling the expansion of the syringe market.

Technological advancements and product innovation are another major trend shaping the market`s trajectory. The development of safety syringes with retractable needles to minimize the risk of accidental needlesticks and the spread of infections is gaining traction. Pre-filled syringes have also emerged as a preferred choice due to their convenience, precise dosing, and reduced preparation time, especially for administering vaccines and biologics. The growth of biologic drugs, which require injectable delivery, supports market demand. Advances in drug formulations are enabling subcutaneous delivery, making at-home treatment feasible for chronic diseases such as autoimmune disorders and certain cancers. This has transformed how pharmaceutical companies approach treatment delivery, encouraging them to decide on the best delivery methods earlier in development. As a result, development processes are streamlined, reducing both costs and testing time. Additionally, the shift toward more eco-friendly, disposable syringes is gaining importance, as hospitals and clinics seek to minimize the environmental impact of medical waste.

Government initiatives and regulations promoting the safe use and disposal of syringes have further influenced market growth. Many regions have implemented policies that mandate the use of safety-engineered syringes to reduce the risk of healthcare-associated infections. Moreover, the global push for mass immunization, particularly in developing countries with large populations, has spurred international organizations to increase funding for syringe procurement and distribution. Sustainability remains a significant concern as single-use auto-injectors and PFS contribute to plastic waste, unlike recyclable glass vials. Nevertheless, these devices have proven advantageous by improving dosing accuracy, reducing medication wastage, and potentially lowering pharmaceutical waste. Their reusable variants offer a solution, potentially mitigating environmental impacts while maintaining user-friendly design. Additionally, fewer administration errors mean better resource conservation.